Study identifies those at high risk for developing pancreatic cancer
the ONA take:
According to new findings published in the journal Digestive and Liver Diseases, an international team of researchers has developed a profile of the patient who would be at highest risk for developing pancreatic lesions that are most likely to develop into cancer.
To determine which patients are at high risk, the researchers analyzed data from 1,126 patients diagnosed with pancreatic lesions.
Of those, 84 developed invasive pancreatic cancer. Results showed that all 84 patients had all or some of the following factors: a history of smoking, a history of obesity, jaundice, and steatorrhea.
Researchers also identified the following risk factors: a larger cyst size, cysts in the main pancreatic duct, and nodules on the cyst wall. The study showed that abdominal pain did not put patients at high risk.
The authors estimate that between 10 and 40% of people have these lesions, but the majority do not develop pancreatic cancer.
The findings may help assure concerned patients who have these lesions that they are not at high risk for developing pancreatic cancer.
Researchers developed a profile of the patient who would be at highest risk for developing pancreatic lesions.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|